Polarean Imaging Plc Total Liabilities
Polarean Imaging Plc total liabilities. Based on the latest financial reports, Polarean Imaging Plc (POLX) has total liabilities worth GBX3.19 Million GBX (≈ $387.94 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See POLX days of operational coverage to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Polarean Imaging Plc (2014–2024)
Total liabilities of Polarean Imaging Plc from 2014 to 2024. This chart illustrates how Polarean Imaging Plc's total liabilities have evolved over time, based on quarterly financial data.
Polarean Imaging Plc Competitors by Total Liabilities
The table below lists competitors of Polarean Imaging Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Plaza Centers NV
LSE:PLAZ
|
UK | GBX205.76 Million |
|
Hana Microelectronics Public Company Limited
F:HAA1
|
Germany | €4.68 Billion |
|
Red Rock Resources
LSE:RRR
|
UK | GBX8.60 Million |
|
PTT Global Chemical Public Company Limited
F:GCB
|
Germany | €310.60 Billion |
|
Fantasy Network Ltd
TA:FNTS
|
Israel | ILA755.00K |
|
Bluebird Merchant Ventures Ltd
LSE:BMV
|
UK | GBX4.64 Million |
|
PTT Public Company Limited
F:PTOG
|
Germany | €1.84 Trillion |
|
Mingzhu Logistics Holdings Ltd
NASDAQ:YGMZ
|
USA | $22.99 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Polarean Imaging Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see POLX total assets.
Liquidity & Leverage Metrics
Polarean Imaging Plc Total Liabilities Ratios Explained
Polarean Imaging Plc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Polarean Imaging Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Polarean Imaging Plc (2014–2024)
The table below shows the annual total liabilities of Polarean Imaging Plc from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | GBX3.65 Million ≈ $444.06 |
+41.23% |
| 2023-12-31 | GBX2.58 Million ≈ $314.42 |
-20.05% |
| 2022-12-31 | GBX3.23 Million ≈ $393.27 |
+15.78% |
| 2021-12-31 | GBX2.79 Million ≈ $339.66 |
+30.02% |
| 2020-12-31 | GBX2.15 Million ≈ $261.23 |
-12.37% |
| 2019-12-31 | GBX2.45 Million ≈ $298.11 |
+20.26% |
| 2018-12-31 | GBX2.04 Million ≈ $247.87 |
-39.25% |
| 2017-12-31 | GBX3.35 Million ≈ $408.04 |
+216.31% |
| 2016-12-31 | GBX1.06 Million ≈ $129.00 |
-6.09% |
| 2015-12-31 | GBX1.13 Million ≈ $137.37 |
-17.35% |
| 2014-12-31 | GBX1.37 Million ≈ $166.20 |
-- |
About Polarean Imaging Plc
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent ind… Read more